$1.11
▼ -1.8% Today
as of Aug 5, 16:54 ET
Last 30 days
Recent Press Releases & News
Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
Overview
52-week range
$0.85
$6.92
4% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
-4.2%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed Dec 31, 2025 | Dec 2025 | $-0.48 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.32 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.37 | — | — | — | — | earnings |
| Tue Jun 17, 2025 | Mar/2025 | $-0.15 | — | — | — | -4.2% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.63 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.59 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.34 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-1.59 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-5.75 | — | — | — | — | financials |
| Wed Jun 21, 2023 | Mar/2023 | $-0.23 | — | — | — | — | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | — | -$0.37 |
Financials
Income statement (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $6M | $4M | — | $4M | $4M | $3M | — |
| Cost of revenue | $3M | $3M | — | — | $2M | $2M | — | — |
| Gross profit | $2M | $2M | $1M | — | $1M | $1M | $1M | — |
| Operating income | $-678,000 | $-337,000 | $-1M | — | $-1M | $-850,000 | $-1M | — |
| Net income | $-819,000 | $-534,000 | $-1M | — | $-928,000 | $-610,000 | $-1M | — |
| EPS (diluted) | $-0.48 | $-0.32 | $-0.76 | — | $-0.63 | $-0.59 | $-1.34 | — |
Balance sheet (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3M | $3M | $4M | $5M | $5M | $4M | $3M | $3M |
| Inventory | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M |
| Total current assets | $12M | $13M | $13M | $13M | $12M | $12M | $12M | $13M |
| Total assets | $14M | $14M | $15M | $14M | $14M | $14M | $14M | $15M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $10M | $10M | $11M | $9M | $9M | $8M | $9M | $9M |
| Total equity | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $6M |
Implied volatility — last 90 days
No IV snapshots yet for SNOA.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.